This document updates SAMHSA’s 2018 document and outlines best practices for the implementation and operation of recovery housing. These best practices are intended to serve as a tool for states, governing bodies, providers, recovery house operators, and other interested stakeholders to improve the health of their citizens, reduce incidence of overdose, and promote recovery housing as a key support strategy in achieving and sustaining recovery.

This guide offers best practices for treating women living with substance use disorders in co-ed treatment and recovery settings. It highlights the importance of gender differences, cultural sensitivity, and developing healthy relationships.

Explica a los consumidores lo que es el bienestar y cómo afecta a la calidad de vida en general, sobre todo para las personas con trastornos de salud mental. Describe las ocho dimensiones del bienestar y ofrece sugerencias sobre cómo las personas pueden aplicarlas a su propia vida para mejorar su bienestar general.

Anima Promueve a que los profesionales de la salud médicos que brinden serviciosa las personas con trastornos de salud mental, servicios que se enfoquen en sus necesidades. Ofrece datos Brinda hechos sobre los trastornos mentales, indican las ocho dimensiones del bienestar, y brinda consejos para colaborar con los proveedores de salud mental.

This resource guide equips mayors and other local public health officials with strategies and resources to shape community responses that promote mental health and substance use disorder recovery, and ensure that needed treatments and services are available.

This guide provides clinicians with questions to begin discussions with adult patients about mental illness, substance use disorders, or both. It includes resources for patients who need an evaluation after a positive screening.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.